 - Subjects will be excluded for any prior use of a TNF-alpha antagonist i.e. etanercept, infliximab, adalimumab andor use of any other immunosuppressant agent i.e. systemic corticosteroids or anti-proliferative agents such as methotrexate within one year of study entry. 